Double Medical Technology Inc.
002901.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.59B
Close$
$17.34
56.4% downside
Current Fair Value
56.4% downsideOvervalued by 56.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16.59 Billion |
|---|---|
| Enterprise Value | $15.88 Billion |
| Dividend Yield | $0.60 (1.50%) |
| Earnings per Share | $1.47 |
| Beta | 0.17 |
| Outstanding Shares | 408,432,653 |
Return
| Return on Equity | 20.15% |
|---|---|
| Return on Assets | 13.76% |
| Return on Invested Capital | 20.27% |
Valuation & Multiples
| P/E Ratio | 23.03 |
|---|---|
| PEG | 49.56 |
| Price to Sales | 6.63 |
| Price to Book Ratio | 4.97 |
| Enterprise Value to Revenue | 5.82 |
| Enterprise Value to EBIT | 19.75 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 26, 2026
EPS Estimate
$0.52
Average shareholder expectationRevenue Estimate
$715.19 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Double Medical Technology Inc.
4,704 employees
CEO: Jiong Luo Double Medical Technology Inc. is a medical enterprise offering a diverse array of services, advanced technologies, and specialized devices. Primarily serving the Chinese market, its core competencies lie in orthopedics, wound management...